between groups, although there was a significant difference between groups in presence of arterial injury (57% 0-10 days vs. 42% 11-90 days vs. 63% >90 days; p=0.011) and mean flap size (350cm vs. 257cm vs. 235cm; p<0.0001). Univariate analysis revealed significant differences in rates of overall success (76% 0-10 days vs. 84% 11-90 days vs. 89% >90 days; p=0.026), partial flap failure (13% vs. 12% vs. 3%; p=0.024), and overall complications (49% vs. 37% vs. 39%; p=0.014). On multivariate analysis, free flaps performed >90 days after initial injury had significantly higher success rates as compared to the 0-10 day group (OR 3.33, p=0.03). The >90 day group also showed a trend toward decreased rates of partial flap failure (OR 0.22, p=0.074). There was no association between time to coverage and rates of total flap failure (p=0.423), overall complications (p=0.272), operative takebacks (p=0.406), or any other outcomes assessed.
between groups, although there was a significant difference between groups in presence of arterial injury (57% 0-10 days vs. 42% 11-90 days vs. 63% >90 days; p=0.011) and mean flap size (350cm vs. 257cm vs. 235cm; p<0.0001) . Univariate analysis revealed significant differences in rates of overall success (76% 0-10 days vs. 84% 11-90 days vs. 89% >90 days; p=0.026), partial flap failure (13% vs. 12% vs. 3%; p=0.024) , and overall complications (49% vs. 37% vs. 39%; p=0.014). On multivariate analysis, free flaps performed >90 days after initial injury had significantly higher success rates as compared to the 0-10 day group (OR 3.33, p=0.03) . The >90 day group also showed a trend toward decreased rates of partial flap failure (OR 0.22, p=0.074) . There was no association between time to coverage and rates of total flap failure (p=0.423), overall complications (p=0.272), operative takebacks (p=0.406), or any other outcomes assessed.
CONCLUSION:
There was no association between timing of reconstruction and rates of total or partial flap failure, overall complications, or operative takebacks. In fact, repairs performed >90 days demonstrated higher success rates. These findings suggest that, in appropriate patients, delayed free flap reconstruction for lower extremity trauma is safe and as effective as early coverage. 
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cost-effective and reliable. Our group has previously introduced implantable oxygen sensors as a mean to monitor flaps in the immediate post-operative period and detect acute vascular compromise. The purpose of the current study was to compare and contrast intradermal vs. subcutaneous implantation of the sensors in their ability to detect flap compromise.
METHODS:
Experimental sensors were made by incorporating benzo-porphyrin dye into a matrix of biocompatible hydrogel. These sensors were approximately 3mm-long, 1.5mm-wide, and 0.5mm-thick. Two groups of male Sprague-Dawley rats had the skin flap site outlined and three sensors were intradermally (ID) implanted at tip, middle and base of the impending flap of one group, while subcutaneously (SQ) implanted in the second group. Corresponding control sensors were implanted laterally at least 1 cm away from the proposed flap in both groups. One day later, the outlined, caudally-based, full thickness flap was elevated on dorsum of rats. Gross flap viability was assessed with computer planimetric analysis. Inspired oxygen was modulated between 100% and 12%. Real-time tissue oxygen tension (TOT) readings were obtained from the sensors on days 0, 3 and 7.
RESULTS:
Oxygen readings by sensors modulated as expected when inspired oxygen was changed, indicating that the sensors are responsive and sensitive within a physiologic range. Gross planimetric analysis of both groups showed that 16% of the flap was necrotic at the tip of the flap as measured on d3 and was more pronounced on d7. Readings from the ID and the SQ sensors have demonstrated statistically significant decreases in oxygenation in all regions of the flap at all time points compared to the control sensors. Overall, SQ implanted sensors showed faster response times than ID implanted sensors. However, ID implantation was less invasive, and makes it easier to localize the sensor for measurement and also avoid migration of the sensor in the SQ plane.
CONCLUSION:
Our analysis revealed that even though both methods are efficacious and accurate in determining changes of oxygenation, SQ sensors responded faster that ID sensors, however ID implantation is easier, less invasive and keep the sensor localized in the specific spot where is it implanted. Vanderbilt University, Nasvhille, TN, USA PURPOSE: Trigger finger (stenosing tenosynovitis) occurs in 2-5% of general population and in up to 10% diabetic patients. First-line treatment involves injection of a corticosteroid, and prior studies have shown cure rates better than 65% with a single injection. Although many surgeons mix local anesthetic with their corticosteroid, the effect of this anesthetic is not clear on the outcomes in treating trigger digits. We conducted a study to compare corticosteroid injections with and without local anesthetic.
METHODS:
In this double-blinded, prospective randomized controlled trial patients were treated with either 1 mL triamcinolone combined with 1 mL of 1% lidocaine or 1 mL of corticosteroid with 1 mL of 0.9% saline. To date, 10 patients have been enrolled with 5 receiving corticosteroidalone and 5 receiving corticosteroid with lidocaine. Pain was the primary outcome, and it was measured using the visual analog scale (VAS) immediately following the injection, and then at 6 hours, 24 hours, and 72 hours after the injection. The efficacy of treatment was also monitored and defined by the need for a repeat injection at 6 weeks.
RESULTS:
The two study groups had similar demographics. The injection containing lidocaine with epinephrine had a higher average VAS compared triamcinolone-only at 1 minute (2.4 vs 1.8) and 6 hours (1.4 vs 1.2), and the same pain score at 72 hours (0.4 vs 0.4) intervals. However, there was no statistical significance in this preliminary analysis. There were no adverse outcomes from the injections.
CONCLUSION:
There is no significant difference in pain outcomes between the injection approaches. However, the single agent injection has a lower cost and risk by involving only one medication. Based on these initial findings, we recommend the use of an injection without lidocaine to treat trigger finger. 
